Multifocal atrial tachycardia
Toggle: English / Spanish
Multifocal atrial tachycardia is a rapid heart rate that occurs when too many signals (electrical impulses) are sent from the upper heart (atria) to the lower heart (ventricles).
Causes, incidence, and risk factors
The human heart gives off electrical impulses, or signals, which tell it to beat. Normally, these signals begin in an area of the upper right chamber called the sinoatrial node (sinus node or SA node). This node is considered the heart's "natural pacemaker." It helps control the heartbeat. When the heart detects a signal, it contracts (or beats).
The normal heart rate in adults is about 60 to 100 beats per minute. The normal heart rate is faster in children.
In multifocal atrial tachycardia (MAT), multiple locations in the atria fire signals at the same time. Too many signals lead to a rapid heart rate -- usually from 100 to 130 beats per minute in adults. The rapid heart rate causes the heart to work too hard and inefficiently. If the heartbeat is very fast, the heart has less time to fill up with blood, so it doesn't have the right amount of blood to pump to the brain and the rest of the body.
MAT is most common in people age 50 and over. It is often seen in people with conditions that lower the amount of oxygen in the blood. These conditions include:
You may be at higher risk for MAT if you have:
When the heart rate is less than 100 beats per minute, the arrhythmia is called "wandering atrial pacemaker."
Some people may have no symptoms. When symptoms occur, they can include:
Other symptoms that can occur with this disease:
Signs and tests
An examination shows a fast irregular heartbeat, usually of 100 to 130 beats per minute. Blood pressure is normal or low. There may be signs of poor circulation.
Tests to diagnose MAT include:
Heart monitors are used to record the rapid heartbeat. These include:
- Portable, long-term loop recorders -- allow you to start recording if symptoms occur
- If you are in the hospital, your heart rhythm will be monitored 24 hours a day
If you have a condition that can lead to MAT, that condition should be treated first.
Treatment for MAT includes:
Improving blood oxygen levels
Giving magnesium or potassium through a vein
Stopping medications, such as theophylline, which can increase the heart rate
Taking medicines to slow the heart rate (if the heart rate is too fast), such as such as calcium channel blockers (verapamil, diltiazem) or beta-blockers
MAT can be controlled if the condition that causes the rapid heartbeat is treated and controlled.
Calling your health care provider
Call your health care provider if:
- You have a rapid or irregular heartbeat with other MAT symptoms
- You have MAT and your symptoms get worse, do not improve with treatment, or you develop new symptoms
To reduce the risk of developing MAT, promptly treat the disorders that cause it.
Olgin JE, Zipes DP. Specific arrhythmias: diagnosis and treatment. In: Bonow RO, Mann DL, Zipes DP, Libby P, eds. Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine. 9th ed. St. Louis, Mo: WB Saunders; 2011:chap 39.
Zimetbaum P. Cardiac arrhythmia with supraventricular origin. In: Goldman L, Schafer AI, eds. Cecil Medicine. 24th ed. Philadelphia, Pa: Saunders Elsevier; 2011:chap 64.
- Last reviewed on 6/18/2012
- David C. Dugdale, III, MD, Professor of Medicine, Division of General Medicine, Department of Medicine, University of Washington School of Medicine; and Michael A. Chen, MD, PhD, Assistant Professor of Medicine, Division of Cardiology, Harborview Medical Center, University of Washington Medical School, Seattle, Washington. Also reviewed by David Zieve, MD, MHA, Medical Director, A.D.A.M. Health Solutions, Ebix, Inc.
The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. © 1997- 2013 A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.
This page was last updated: May 20, 2014